Oral Contraceptive Progestin and Estrogen Use and Increases in Breast, Ovarian, and Endometrial Cancers - Reply

Kara A. Michels; Britton Trabert

doi:10.1001/jamaoncol.2018.4166

Oral Contraceptive Progestin and Estrogen Use and Increases in Breast, Ovarian, and Endometrial Cancers - Reply

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	1623-1624
Number of pages	2
Journal	JAMA Oncology
Volume	4
Issue number	11
DOIs	https://doi.org/10.1001/jamaoncol.2018.4166
State	Published - Nov 2018
Externally published	Yes

ASJC Scopus subject areas

Oncology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1001/jamaoncol.2018.4166

Cite this

@article{05a706abccf6471a9bf39fda950336fa,

title = "Oral Contraceptive Progestin and Estrogen Use and Increases in Breast, Ovarian, and Endometrial Cancers - Reply",

author = "Michels, {Kara A.} and Britton Trabert",

note = "Funding Information: Funding/Support: This research was supported by the Intramural Research Program of the National Cancer Institute at the National Institutes of Health.",

year = "2018",

month = nov,

doi = "10.1001/jamaoncol.2018.4166",

language = "English (US)",

volume = "4",

pages = "1623--1624",

journal = "JAMA Oncology",

issn = "2374-2437",

publisher = "American Medical Association",

number = "11",

}

TY - JOUR

T1 - Oral Contraceptive Progestin and Estrogen Use and Increases in Breast, Ovarian, and Endometrial Cancers - Reply

AU - Michels, Kara A.

AU - Trabert, Britton

N1 - Funding Information: Funding/Support: This research was supported by the Intramural Research Program of the National Cancer Institute at the National Institutes of Health.

PY - 2018/11

Y1 - 2018/11

UR - http://www.scopus.com/inward/record.url?scp=85053710631&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85053710631&partnerID=8YFLogxK

U2 - 10.1001/jamaoncol.2018.4166

DO - 10.1001/jamaoncol.2018.4166

M3 - Letter

C2 - 30242311

AN - SCOPUS:85053710631

SN - 2374-2437

VL - 4

SP - 1623

EP - 1624

JO - JAMA Oncology

JF - JAMA Oncology

IS - 11

ER -

Oral Contraceptive Progestin and Estrogen Use and Increases in Breast, Ovarian, and Endometrial Cancers - Reply

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this